Myriad Genetics
MYGN
MYGN
186 hedge funds and large institutions have $2B invested in Myriad Genetics in 2024 Q1 according to their latest regulatory filings, with 21 funds opening new positions, 72 increasing their positions, 63 reducing their positions, and 29 closing their positions.
Holders
186
Holders Change
-8
Holders Change %
-4.12%
% of All Funds
2.7%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
21
Increased
72
Reduced
63
Closed
29
Calls
$6.32M
Puts
$324K
Net Calls
+$6M
Net Calls Change
+$4.27M
Top Buyers
Top Sellers
1 |
1
D.E. Shaw & Co
New York
|
$27M |
2 |
2
Bank of America
Charlotte,
North Carolina
|
$56.4M |
3 |
GCM
3
Glenview Capital Management
New York
|
$105M |
4 |
4
Goldman Sachs
New York
|
$19.4M |
5 |
5
Envestnet Asset Management
Chicago,
Illinois
|
$1.45M |